Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eric Cuevas"'
Autor:
Pamela Ramírez, MD, Eric Cuevas, MD, José Antonio Cornejo, MD, Sergio Olvera, MD, Jorge Aceituno, MD, Gabriela Meléndez, MD, PhD, Luis Baeza, MD
Publikováno v:
CJC Open, Vol 3, Iss 9, Pp 1189-1191 (2021)
About 90% of cases of acute pericarditis have an idiopathic or viral etiology. In some cases, it is possible to identify high-risk patients for whom hospital admission and specific etiology research are mandatory for adequate treatment. Bacterial per
Externí odkaz:
https://doaj.org/article/9c0e0c256fe143fd9fd9074b18efc216
Autor:
Norma O. Uribe-Uribe, Alan G. Contreras, Luis E. Morales-Buenrostro, Josefina Alberú, José M. Arreola-Guerra, José Argenis López-Sánchez, Alberto González-Almada, Eric Cuevas, Mario Vilatobá
Publikováno v:
Transplant Immunology. 54:1-8
The association between anti-AT1Rabs and microvascular injury observed in antibody-mediated rejection has been described in kidney graft Biopsies (KGBx).We herein describe the histopathologic findings of KGBx performed during the first year of transp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ece983461531f0272c5c483d7da887b
https://doi.org/10.1016/j.trim.2018.10.003
https://doi.org/10.1016/j.trim.2018.10.003
Autor:
Eric Cuevas, Julio Granados, Alan Contreras-Saldívar, David de Rungs, Isaac Salcedo, Aczel Sánchez-Cedillo, M. Vilatobá, Luis E. Morales-Buenrostro, José M. Arreola-Guerra, Erick Alejandro Hernández-Méndez, Norma O. Uribe-Uribe, Josefina Alberú, Natalia Castelán, Julia B Ramírez
Publikováno v:
Nephrology Dialysis Transplantation. 31:1738-1745
BACKGROUND Angiotensin II type 1 receptor antibodies (AT1Rabs) have been associated with significantly reduced graft survival. Earlier graft loss has been observed in patients who had pretransplant AT1Rabs and posttransplant donor-specific antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea48b1d0d73470eae2f97e20e4ed9a46
https://doi.org/10.1093/ndt/gfw204
https://doi.org/10.1093/ndt/gfw204
Autor:
Eduardo Mancilla-Urrea, Félix Recillas-Targa, M. Vilatobá, Evelyn Katy Alvarez Salazar, David de Rungs, Germán R. Alemán-Muench, Jesús Rafael Rodríguez-Aguilera, Eric Cuevas, Arimelek Cortés-Hernández, Victoria Chagoya de Sánchez, Guillermo Mondragón-Ramírez, Ian C. Bostock, María Pérez García, Erick Alejandro Hernández-Méndez, Gloria Soldevila, Josefina Alberú, Eduardo A. García-Zepeda
Publikováno v:
Frontiers in Immunology
Regulatory T cells (Tregs) are considered key players in the prevention of allograft rejection in transplanted patients. Belatacept (BLT) is an effective alternative to calcineurin inhibitors that appears to preserve graft survival and function; howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8124a5a25596c1f8595b58a7d057ed89
https://doi.org/10.3389/fimmu.2017.00219
https://doi.org/10.3389/fimmu.2017.00219